
In 1983 Started as a Marketing Company;1995: Backward integration with API manufacturing 1997: Acquired Antibiotic facility at Bavla (Ahmedabad) 2006: Vapi Manufacturing plant received US FDA approval 2007: Bavla Manufacturing plant received US FDA approval 2008: Commissioned a new dedicated facility for Carbapenem.Oncology facility (for high potency compounds) under execution. Acquired majority stake in KDL Biotech Ltd
Unimark, a vertically integrated healthcare company, aims in developing affordable generic medicines in various therapeutic segments such as respiratory, cardiovascular, anti-infectives, central nervous system for global markets. We believe in introducing affordable generic formulations establishing a remarkable global benchmark.
Unimark has a diversified business portfolio that includes healthcare products ranging from diagnostics, devices, finished formulations, cosmeceuticals, animal healthcare products, active pharmaceutical ingredients.
Unimark has a diversified business portfolio that includes healthcare products ranging from diagnostics, devices, finished formulations, cosmeceuticals, animal healthcare products, active pharmaceutical ingredients.
Mehul
Executive Director
R.O.19, Crystal, 1st Floor, Juhu Road, Santacruz (W),(Opp) Bank of Baroda
Mumbai,Maharashtra,400054,IN.